Back to results
US 2021/0230282 A1Published application
Prophylactic agent, onset-suppressing agent or therapeutic agent for progressive immune demyelinating diseases
AssigneeNational Center of Neurology and Psychiatry
InventorsShinji OKI, Takashi YAMAMURA
Life of this patent
Estimating the term…
Abstract
The present invention provides a prophylactic agent, onset-suppressing agent, or therapeutic agent for progressive immune demyelinating diseases comprising, as an active ingredient, a substance capable of suppressing or inhibiting production of prolactin.
Claims9
1-15:
- (canceled)
A method for preventing, or for suppressing progression into a late stage of a progressive immune demyelinating disease in a subject, comprising administering, to the subject, a substance capable of suppressing or inhibiting activation of CX3CR1 receptor.
Dependencies are inferred from the claim text.